| 标题： | KSUMC Evidence-Based Clinical Practice Guideline for Venous Thromboembolism Prophylaxis |
| 版本： | 更新版 |
| 分类： | 标准指南 |
| 领域： | 预防 |
| 国家和地区： | 沙特阿拉伯 |
| 指南使用者： | The targeted users of this CPG are healthcare providers in both primary and specialty care who assist patients in making treatment choices that optimize benefits, minimize harms and burdens, and are consistent with patient values and preferences, which include:- Physicians Advanced Practice Nurses Allied Health Personnel Nurses Pharmacists Physiotherapists Patients Psychologists/Non-physician Behavioral Health Clinicians Social Workers |
| 证据分级方法： | The description of the methodology for the production of this adapted CPG can be fulfilled by utilizing the King Saud University (KSU) Modified ADAPTE method. This CPG formal adaptation method included three phases (setup, adaptation, and finalization), nine modules, and 24 steps with modifications in the steps and tools to suit the local general healthcare setting in Saudi Arabia. Overall, the steps of CPG adaptation included the selection of the health topic, formulation of the CPG adaptation working group, identification of health questions using the PIPOH model, searching and selecting Source CPGs with clear inclusion and exclusion criteria, quality assessment of included Source CPGs by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, assessment of the currency of the selected Source CPG, drafting of the adapted CPG, external review and consultation process, finalization of the adapted CPG with a set of implementation tools, declaration of conflicts of interests, and finally a plan for review and update. For further details on the specific modifications in steps and tools, refer to the article by Amer et al. 2019 (https://doi.org/10.1111/jep.12927). |
| 制定单位： | King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia |
| 注册时间： | 2022-03-19 |
| 注册编号： | IPGRP-2022CN160 |
| 指南制订的目的： | 1. To optimize patient-important health outcomes and the process of care for patients who are at risk for deep venous thromboembolism events in critical care units. 2. To review the risks of venous thromboembolism (VTE) in various patient groups. 3. To discuss the prevention of VTE 4. To update evidence-based recommendations for the use of measures to prevent VTE |
最新注册
